연구성과로 돌아가기
JCR 2024 저널 목록 (1652 / 2104)
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Journal Name | Publisher | ISSN | eISSN | Edition | WoS Category | Total Citation | JIF | JIF Quartile | 상위 JCR(%) | JIF % | JIF Rank | 5-Year JIF | 5-Year Quartile | JIF w/o Self-Cites | Immediacy Index | JCI | JCI Rank | JCI Quartile | JCI Percentile | Eigenfactor Score | Normalized Eigenfactor | Article Influence Score | AIS Quartile | Citable Items | Articles in Citable Items (%) | Cited Half-Life | Citing Half-Life | Total Articles | Citable OA (%) | 수집시기 | 바로가기 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CLINICAL NEUROPATHOLOGY | DUSTRI-VERLAG DR KARL FEISTLE | 0722-5091 | 0722-5091 | SCIE | PATHOLOGY | 750 | 0.8 | Q4 | 85.0 | 15.0 | 77/90 | 0.9 | Q4 | 0.8 | 0.1 | 0.25 | 80/90 | Q4 | 11.67 | 0.000 | 0.064 | 0.264 | Q4 | 13 | 84.6% | 13.9 | 12.6 | 11 | 0.0% | 2025-08-05 16:04:31 | 바로가기 |
| European Heart Journal-Case Reports | OXFORD UNIV PRESS | N/A | 2514-2119 | ESCI | CARDIAC & CARDIOVASCULAR SYSTEMS | 1,549 | 0.8 | Q4 | 85.0 | 15.0 | 196/230 | 0.7 | Q4 | 0.7 | 0.1 | 0.20 | 201/230 | Q4 | 12.83 | 0.003 | 0.722 | 0.217 | Q4 | 546 | 100.0% | 3.2 | 6.8 | 546 | 97.4% | 2025-08-05 16:02:37 | 바로가기 |
| IET Systems Biology | INST ENGINEERING TECHNOLOGY-IET | 1751-8849 | 1751-8857 | SCIE | CELL BIOLOGY | 517 | 1.9 | Q4 | 85.0 | 15.0 | 174/204 | 1.7 | Q4 | 1.9 | 0.2 | 0.43 | 157/204 | Q4 | 23.28 | 0.000 | 0.086 | 0.346 | Q4 | 26 | 100.0% | 6.2 | 5.5 | 26 | 94.0% | 2025-08-05 16:02:38 | 바로가기 |
| IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-PLANT | SPRINGER | 1054-5476 | 1475-2689 | SCIE | CELL BIOLOGY | 3,028 | 1.9 | Q4 | 85.0 | 15.0 | 174/204 | 2.1 | Q4 | 1.7 | 0.4 | 0.52 | 135/204 | Q3 | 34.07 | 0.001 | 0.215 | 0.280 | Q4 | 76 | 93.4% | 10.4 | 9.6 | 71 | 12.2% | 2025-08-05 16:02:38 | 바로가기 |
| JAPANESE JOURNAL OF INFECTIOUS DISEASES | NATL INST INFECTIOUS DISEASES | 1344-6304 | 1884-2836 | SCIE | INFECTIOUS DISEASES | 1,751 | 1.1 | Q4 | 85.0 | 15.0 | 117/137 | 1.2 | Q4 | 1.0 | 0.7 | 0.38 | 109/137 | Q4 | 20.80 | 0.001 | 0.252 | 0.309 | Q4 | 48 | 95.8% | 8.8 | 7.7 | 46 | 85.5% | 2025-08-05 16:03:36 | 바로가기 |
| Journal of Cardiovascular Emergencies | SCIENDO | 2457-5518 | 2457-550X | ESCI | CARDIAC & CARDIOVASCULAR SYSTEMS | 59 | 0.8 | Q4 | 85.0 | 15.0 | 196/230 | 0.5 | Q4 | 0.7 | 0.4 | 0.26 | 187/230 | Q4 | 18.91 | 0.000 | 0.012 | 0.081 | Q4 | 20 | 80.0% | N/A | 5.8 | 16 | 100.0% | 2025-08-05 16:02:37 | 바로가기 |
| Journal of Global Infectious Diseases | WOLTERS KLUWER MEDKNOW PUBLICATIONS | 0974-777X | 0974-8245 | ESCI | INFECTIOUS DISEASES | 1,081 | 1.1 | Q4 | 85.0 | 15.0 | 117/137 | 1.8 | Q4 | 1.1 | 0.2 | 0.21 | 124/137 | Q4 | 9.85 | 0.001 | 0.121 | 0.424 | Q4 | 27 | 100.0% | 10.3 | 7.6 | 27 | 98.9% | 2025-08-05 16:03:36 | 바로가기 |
| Journal of the Association of Medical Microbiology and Infectious Disease Canada (JAMMI) | UNIV TORONTO PRESS INC | N/A | 2371-0888 | ESCI | INFECTIOUS DISEASES | 199 | 1.1 | Q4 | 85.0 | 15.0 | 117/137 | N/A | N/A | 1.0 | 0.3 | 0.24 | 121/137 | Q4 | 12.04 | 0.000 | 0.105 | N/A | N/A | 40 | 100.0% | 3.1 | 5.7 | 40 | 0.9% | 2025-08-05 16:03:37 | 바로가기 |
| Kardiologie | SPRINGER HEIDELBERG | 2731-7129 | 2731-7137 | ESCI | CARDIAC & CARDIOVASCULAR SYSTEMS | 189 | 0.8 | Q4 | 85.0 | 15.0 | 196/230 | 0.7 | Q4 | 0.5 | 0.2 | 0.24 | 190/230 | Q4 | 17.61 | 0.000 | 0.036 | 0.107 | Q4 | 51 | 52.9% | 3.8 | 4.9 | 27 | 7.6% | 2025-08-05 16:02:37 | 바로가기 |
| LEPROSY REVIEW | LEPRA | 0305-7518 | 2162-8807 | SCIE | PATHOLOGY | 770 | 0.8 | Q4 | 85.0 | 15.0 | 77/90 | 0.7 | Q4 | 0.7 | 0.3 | 0.22 | 83/90 | Q4 | 8.33 | 0.000 | 0.071 | 0.208 | Q4 | 12 | 100.0% | 14.7 | 13.0 | 12 | 100.0% | 2025-08-05 16:04:31 | 바로가기 |
| Population Review | SOCIOLOGICAL DEMOGRAPHY PRESS | 1549-0955 | 1549-0955 | ESCI | DEMOGRAPHY | 122 | 0.4 | Q4 | 85.0 | 15.0 | 43/50 | 0.8 | Q4 | 0.4 | <0.1 | 0.19 | 44/50 | Q4 | 13.00 | 0.000 | 0.018 | 0.186 | Q4 | 13 | 100.0% | 8.0 | 12.3 | 13 | 0.0% | 2025-08-05 16:02:50 | 바로가기 |
| Revista Iberoamericana de Estudios Municipales | UNIV AUTONOMA CHILE, INST CHILENO ESTUDIOS MUNICIPALES | 0718-8838 | 0719-1790 | ESCI | PUBLIC ADMINISTRATION | 33 | 0.5 | Q4 | 85.0 | 15.0 | 77/90 | 0.4 | Q4 | 0.4 | <0.1 | 0.04 | 88/90 | Q4 | 2.78 | 0.000 | 0.013 | 0.135 | Q4 | 12 | 100.0% | N/A | 8.0 | 12 | 93.1% | 2025-08-05 16:04:58 | 바로가기 |
| Voprosy Gosudarstvennogo i Munitsipalnogo Upravleniya-Public Administration Issues | NATL RES UNIV HIGHER SCH ECONOMICS | 1999-5431 | 1999-5431 | ESCI | PUBLIC ADMINISTRATION | 122 | 0.5 | Q4 | 85.0 | 15.0 | 77/90 | 0.3 | Q4 | 0.3 | <0.1 | 0.17 | 77/90 | Q4 | 15.00 | 0.000 | 0.029 | 0.067 | Q4 | 31 | 100.0% | 4.0 | 7.9 | 31 | 98.4% | 2025-08-05 16:04:58 | 바로가기 |
| ALDRICHIMICA ACTA | ALDRICH CHEMICAL CO INC | 0002-5100 | N/A | SCIE | CHEMISTRY, ORGANIC | 260 | 0.8 | Q4 | 85.1 | 14.9 | 49/57 | 1.4 | Q3 | 0.8 | <0.1 | 0.34 | 40/57 | Q3 | 30.70 | 0.000 | 0.018 | 0.383 | Q2 | 2 | 100.0% | 12.4 | 10.2 | 2 | 0.0% | 2025-08-05 16:02:41 | 바로가기 |
| Annales Pharmaceutiques Francaises | MASSON EDITEUR | 0003-4509 | 0003-4509 | ESCI | PHARMACOLOGY & PHARMACY | 799 | 1.1 | Q4 | 85.1 | 14.9 | 300/352 | 1.1 | Q4 | 1.0 | 0.6 | 0.30 | 295/353 | Q4 | 16.57 | 0.000 | 0.101 | 0.163 | Q4 | 102 | 92.2% | 4.9 | 7.3 | 94 | 0.0% | 2025-08-05 16:04:35 | 바로가기 |
페이지 이동: